Have a personal or library account? Click to login
Fetal Growth Abnormalities in Overweight and Obese Pregnant Women: A Study Among Bulgarian Pregnant Women Cover

Fetal Growth Abnormalities in Overweight and Obese Pregnant Women: A Study Among Bulgarian Pregnant Women

By: I. Hristova,  E. Naseva and  M. Yunakova  
Open Access
|Feb 2026

References

  1. Popovski N, Nikolov A, Lukanov T, et al. Changes of serum angiotensin peptides, pro-endothelin-1 levels in women one year after preeclampsia and their association with cardiovascular risk factors. Acta Medica Bulgarica, 2023, 50(4):19-27.
  2. Nikolov A, Popovski N, Hristova I. Association between serum matrix metalloproteinase-2 levels and mean doppler pulsatility index of uterine arteries in patients with preeclampsia. Acta Medica Bulgarica. 2022, 49 (3):19-24.
  3. Sharma D, Shastri S, Sharma P. Intrauterine Growth Restriction: Antenatal and Postnatal Aspects. Clin Med Insights Pediatr. 2016;10.
  4. Lees CC, Stampalija T, Baschat A, et al. ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction. Ultrasound in Obstetrics and Gynecology, 2020, 56(2):298–312.
  5. Salomon LJ, Alfirevic Z, Berghella V, et al. ISUOG Practice Guidelines (updated): performance of the routine mid-trimester fetal ultrasound scan. Ultrasound in Obstetrics and Gynecology, 2022, 59(6):840–56.
  6. Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013;13(1):1–13.
  7. Rosenberg A. The IUGR Newborn. Semin Perinatol, 2008, 32(3):219–24.
  8. Genova MP, Todorova-Ananieva K, Atanasova B, et al. Assessment of beta-cell function during pregnancy and after delivery. Acta Medica Bulgarica, 2014, XLI(1):5-12.
  9. Genova MP, Todorova-Ananieva K, Atanasova B, et al. Proinsulin in healthy pregnancy, pregnancy with gestational diabetes and after delivery. Acta Medica Bulgarica. 2014;XLI(1):13:21.
  10. Higgins L, Greenwood SL, Wareing M, et al. Obesity and the placenta: A consideration of nutrient exchange mechanisms in relation to aberrant fetal growth. Placenta, 2011, 32(1):1–7.
  11. Alcala M, Gutierrez-Vega S, Castro E, et al. Antioxidants and oxidative stress: Focus in obese pregnancies. Front Physiol. 2018;9(NOV):413463.
  12. Delhaes F, Giza SA, Koreman T, et al. Altered maternal and placental lipid metabolism and fetal fat development in obesity: Current knowledge and advances in non-invasive assessment. Placenta, 2018, 69:118–24.
  13. Howell KR, Powell TL. Effects of maternal obesity on placental function and fetal development. Reproduction. 2016;153(3):R97.
  14. Radulescu L, Munteanu O, Popa F, et al. The implications and consequences of maternal obesity on fetal intrauterine growth restriction. J Med Life. 2013;6(3):292.
  15. Tanner LD, Brock C, Chauhan SP. Severity of fetal growth restriction stratified according to maternal obesity. The Journal of Maternal-Fetal & Neonatal Medicine. 2022;35(10):1886–90.
  16. Catalano PM, Mele L, Landon MB, et al. Inadequate weight gain in overweight and obese pregnant women: what is the effect on fetal growth? Am J Obstet Gynecol, 2014, 211(2):137.e1-137.e7.
  17. Simko M, Totka A, Vondrova D, et al. Maternal Body Mass Index and Gestational Weight Gain and Their Association with Pregnancy Complications and Perinatal Conditions. International Journal of Environmental Research and Public Health, 2019, 16:1751. 2019;16(10):1751.
  18. Najafian M, Cheraghi M, Czeizel AE, et al. Occurrence of Fetal Macrosomia Rate and Its Maternal and Neonatal Complications: A 5-Year Cohort Study. Int Sch Res Notices. 2012;2012(1):353791.
  19. Kong L, Nilsson IAK, Gissler M, et al. Associations of Maternal Diabetes and Body Mass Index With Offspring Birth Weight and Prematurity. JAMA Pediatr. 2019;173(4):371–8.
  20. Lewandowska M. Maternal obesity and risk of low birth weight, fetal growth restriction, and macrosomia: Multiple analyses. Nutrients. 2021;13(4):1213.
  21. Rosario FJ, Kanai Y, Powell TL, et al. Increased placental nutrient transport in a novel mouse model of maternal obesity with fetal overgrowth. Obesity. 2015;23(8):1663–70.
  22. Yu Z, Han S, Zhu J, et al. Pre-Pregnancy Body Mass Index in Relation to Infant Birth Weight and Offspring Overweight/Obesity: A Systematic Review and Meta-Analysis. PLoS One. 2013;8(4):e61627.
  23. Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstetrics and gynecology. 2004;103(2):219–24.
  24. Weindling AM. The confidential enquiry into maternal and child health (CEMACH). Arch Dis Child. 2003;88(12):1034–7.
  25. Ratnasiri AWG, Lee HC, Lakshminrusimha S, et al. Trends in maternal prepregnancy body mass index (BMI) and its association with birth and maternal outcomes in California, 2007–2016: A retrospective cohort study. PLoS One. 2019;14(9):e0222458.
  26. Longo S, Bollani L, Decembrino L, et al. Short-term and long-term sequelae in intrauterine growth retardation (IUGR). The Journal of Maternal-Fetal & Neonatal Medicine. 2013;26(3):222–5.
  27. Yordanov Y. Probiotic Use in Preterm Neonates: A Review and Bibliometric Analysis. Acta Medica Bulgarica, 2022, 49(3):58–67.
  28. Barker DJP, Osmond C, Winter PD, et al. Weight In Infancy And Death From Ischaemic Heart Disease. The Lancet, 1989, 334(8663):577–80.
  29. Girchenko P, Tuovinen S, Lahti-Pulkkinen M, et al. Maternal early pregnancy obesity and related pregnancy and pre-pregnancy disorders: associations with child developmental milestones in the prospective PREDO Study. International Journal of Obesity 2018; 42:995–1007.
  30. Kanda T, Murai-Takeda A, Kawabe H, et al. Low birth weight trends: possible impacts on the prevalences of hypertension and chronic kidney disease. Hypertension Research. 2020 May 11;43(9):859–68.
  31. Zhang J, Peng L, Chang Q, et al. Maternal obesity and risk of cerebral palsy in children: a systematic review and meta-analysis. Dev Med Child Neurol. 2019 Jan 1;61(1):31–8.
  32. Ingul CB, Lorås L, Tegnander E, et al. Maternal obesity affects fetal myocardial function as early as in the first trimester. Ultra-sound in Obstetrics & Gynecology. 2016 Apr 1;47(4):433–42.
  33. Mahizir D, Briffa JF, Hryciw DH, et al. Maternal obesity in females born small: Pregnancy complications and offspring disease risk. Mol Nutr Food Res. 2016 Jan 1;60(1):8–17.
  34. Yao S, Lopez-Tello J, Sferruzzi-Perri AN. Developmental programming of the female reproductive system – a review. Biol Reprod. 2021 Apr 1;104(4):745–70.
  35. Wei W, Zhang X, Zhou B, et al. Effects of female obesity on conception, pregnancy and the health of offspring. Front Endocrinol (Lausanne). 2022 Aug 11;13:949228.
  36. Willging MM, Abbott DH, Dumesic DA. Intergenerational Implications of PCOS. Polycystic Ovary Syndrome: Current and Emerging Concepts. 2022 Apr 13; 555–76.
  37. Alfaradhi MZ, Ozanne SE. Developmental programming in response to maternal overnutrition. Front Genet. 2011 Jun 3;2(JUNE):10532.
  38. Blackmore HL, Ozanne SE. Programming of cardiovascular disease across the life-course. J Mol Cell Cardiol, 2015, 83:122–30.
  39. Heslehurst N, Vieira R, Akhter Z, et al. The association between maternal body mass index and child obesity: A systematic review and meta-analysis. PLoS Med. 2019 Jun 1;16(6):e1002817.
DOI: https://doi.org/10.2478/amb-2026-0001 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750
Language: English
Page range: 6 - 14
Submitted on: Jul 7, 2025
|
Accepted on: Jul 15, 2025
|
Published on: Feb 21, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 I. Hristova, E. Naseva, M. Yunakova, published by Medical University - Sofia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.